Angelica Kottkamp

11PUBLICATIONS
87CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsVenereologyPeripheral nervous systemBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 25, 2026
The vaccine platform used for COVID-19 primary immunization shapes the quality of the human B cell response to a vaccine boost.

Noemia S Lima, Lauren McCormick, Samuel Li

|Oct 10, 2025
Historical Advances in Clinical Trial Design and Expanding Representation as the New Frontier for Innovation.

Kathryn Jano, Tara M Babu, Angelica C Kottkamp

|Apr 29, 2025
Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.

Robert L Atmar, Kirsten E Lyke, Christine M Posavad

|Jan 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost.

Bo Zhang, Youyi Fong, Lauren Dang

|Dec 13, 2023
Antibody Titers against Mpox Virus after Vaccination.

Angelica C Kottkamp, Marie I Samanovic, Ralf Duerr

|Aug 28, 2023
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.

Angela R Branche, Nadine G Rouphael, David J Diemert

Pageof 2

Frequent Collaborators

6 joint publications

Robert L Atmar

5 joint publications

Paul C Roberts

5 joint publications

Angela R Branche

5 joint publications

Kirsten Lyke